Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kent

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Clinical Trials (London, England)|May 6, 2023
Overall average treatment effects from clinical trials, one-variable-at-a-time subgroup analyses and predictive approaches to heterogeneous treatment effects: Toward a more patient-centered evidence-based medicineDavid M Kent
Stroke|September 24, 2005
Improved perioperative outcomes from carotid endarterectomy: yet another statin side effect?David M Kent
The New England Journal of Medicine|August 11, 2006
Stroke--an equal opportunity for the initiation of statin therapyDavid M Kent
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 21, 2015
Toward a modern era in clinical prediction: the TRIPOD statement for reporting prediction modelsNavdeep Tangri, David M Kent
ACP Journal Club|February 7, 2002
The Framingham scores overestimated the risk for coronary heart disease in Japanese, Hispanic, and Native American cohortsDavid M Kent, John Griffith
Trials|July 8, 2009
Against pragmatism: on efficacy, effectiveness and the real worldDavid M Kent, Georgios Kitsios
JAMA|May 10, 2012
Prognostic models for older adultsEzra Gabbay, David M Kent
Neurologic Clinics|April 25, 2015
Prevention of recurrent stroke in patients with patent foramen ovaleBenjamin S Wessler, David M Kent
JAMA|July 18, 2008
6 EZ steps to improving your performance: (or how to make P4P pay 4U!)Rodney A Hayward, David M Kent
Annals of Internal Medicine|April 14, 2015
The Lake Wobegon Effect: Why Most Patients Are at Below-Average RiskAndrew J Vickers, David M Kent
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Clinical Trials (London, England)|May 6, 2023
Overall average treatment effects from clinical trials, one-variable-at-a-time subgroup analyses and predictive approaches to heterogeneous treatment effects: Toward a more patient-centered evidence-based medicineDavid M Kent
Stroke|September 24, 2005
Improved perioperative outcomes from carotid endarterectomy: yet another statin side effect?David M Kent
The New England Journal of Medicine|August 11, 2006
Stroke--an equal opportunity for the initiation of statin therapyDavid M Kent
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 21, 2015
Toward a modern era in clinical prediction: the TRIPOD statement for reporting prediction modelsNavdeep Tangri, David M Kent
ACP Journal Club|February 7, 2002
The Framingham scores overestimated the risk for coronary heart disease in Japanese, Hispanic, and Native American cohortsDavid M Kent, John Griffith
Trials|July 8, 2009
Against pragmatism: on efficacy, effectiveness and the real worldDavid M Kent, Georgios Kitsios
JAMA|May 10, 2012
Prognostic models for older adultsEzra Gabbay, David M Kent
Neurologic Clinics|April 25, 2015
Prevention of recurrent stroke in patients with patent foramen ovaleBenjamin S Wessler, David M Kent
JAMA|July 18, 2008
6 EZ steps to improving your performance: (or how to make P4P pay 4U!)Rodney A Hayward, David M Kent
Annals of Internal Medicine|April 14, 2015
The Lake Wobegon Effect: Why Most Patients Are at Below-Average RiskAndrew J Vickers, David M Kent
Pageof 27